In metastatic melanoma patients undergoing ICI therapy, NK cell infiltration into tumor was correlated with favorable response to anti-PD-1 therapy, even in the event of tumor MHC-I downregulation (54). This evidence concerns the gene PDCD1 and neoplasm.